iSAM Funds UK Ltd Takes $531,000 Position in Cabot Co. (NYSE:CBT)

iSAM Funds UK Ltd acquired a new position in shares of Cabot Co. (NYSE:CBT) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 5,820 shares of the specialty chemicals company’s stock, valued at approximately $531,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. R Squared Ltd bought a new position in Cabot during the 4th quarter worth approximately $26,000. EverSource Wealth Advisors LLC boosted its stake in Cabot by 37.2% during the 4th quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company’s stock worth $74,000 after acquiring an additional 219 shares during the last quarter. Manchester Capital Management LLC boosted its stake in Cabot by 1,685.1% during the 4th quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company’s stock worth $153,000 after acquiring an additional 1,584 shares during the last quarter. KBC Group NV boosted its stake in Cabot by 43.1% during the 4th quarter. KBC Group NV now owns 2,046 shares of the specialty chemicals company’s stock worth $187,000 after acquiring an additional 616 shares during the last quarter. Finally, Measured Wealth Private Client Group LLC bought a new position in Cabot during the 4th quarter worth approximately $205,000. Institutional investors own 93.18% of the company’s stock.

Cabot Stock Performance

Shares of CBT stock opened at $75.76 on Tuesday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.29 and a current ratio of 2.00. The company has a market capitalization of $4.07 billion, a P/E ratio of 10.06, a price-to-earnings-growth ratio of 0.74 and a beta of 0.91. The company’s 50 day moving average price is $79.18 and its two-hundred day moving average price is $89.61. Cabot Co. has a 52 week low of $71.64 and a 52 week high of $117.46.

Cabot (NYSE:CBT) last announced its quarterly earnings data on Monday, May 5th. The specialty chemicals company reported $1.90 EPS for the quarter, topping analysts’ consensus estimates of $1.86 by $0.04. The business had revenue of $936.00 million for the quarter, compared to analyst estimates of $1.02 billion. Cabot had a net margin of 10.60% and a return on equity of 26.79%. The firm’s revenue for the quarter was down 8.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.78 earnings per share. On average, analysts expect that Cabot Co. will post 7.57 earnings per share for the current fiscal year.

Cabot Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 30th will be given a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.38%. The ex-dividend date is Friday, May 30th. This is a positive change from Cabot’s previous quarterly dividend of $0.43. Cabot’s payout ratio is currently 23.29%.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. UBS Group dropped their target price on shares of Cabot from $93.00 to $83.00 and set a “neutral” rating on the stock in a report on Monday, April 7th. JPMorgan Chase & Co. dropped their target price on shares of Cabot from $105.00 to $85.00 and set an “underweight” rating on the stock in a report on Friday, February 21st. Finally, StockNews.com downgraded shares of Cabot from a “buy” rating to a “hold” rating in a report on Wednesday, May 7th.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.